Jack Kaye
CIK: 0001376099
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Jun 30, 2026QURE
uniQure N.V.
Exercise(M)Direct17.1K shares at avg. $20.18$344K - Jun 30, 2026QURE
uniQure N.V.
Sale(S)Direct17.1K shares at avg. $46.43$792K - Jun 30, 2026QURE
uniQure N.V.
Sale(S)Direct4.1K shares at avg. $46.49$191K - Jun 30, 2026QURE
uniQure N.V.
Exercise(M)Direct4.1K shares at avg. $37.00$152K - Jun 17, 2026QURE
uniQure N.V.
Sale(S)Direct5.3K shares at avg. $42.57$225K - Jun 17, 2026QURE
uniQure N.V.
Exercise(M)Direct5.3K shares at avg. $31.71$168K - Jun 11, 2026QURE
uniQure N.V.
Sale(S)Direct2K shares at avg. $27.06$54K - Jun 10, 2026QURE
uniQure N.V.
Award(A)Direct7.6K shares- - Jun 3, 2026QURE
uniQure N.V.
Exercise(M)Direct2.6K shares at avg. $16.04$42K - Jun 3, 2026QURE
uniQure N.V.
Sale(S)Direct2.6K shares at avg. $30.01$79K - Jan 9, 2026QURE
uniQure N.V.
Exercise(M)Direct6.4K shares at avg. $19.39$124K - Jan 9, 2026QURE
uniQure N.V.
Sale(S)Direct6.4K shares at avg. $27.28$174K - Jan 2, 2026DYAI
DYADIC INTERNATIONAL INC
Award(A)DirectRestricted Stock Unit
39.9K shares- - Jan 2, 2026DYAI
DYADIC INTERNATIONAL INC
Exercise(M)Direct21.6K shares- - Jan 2, 2026DYAI
DYADIC INTERNATIONAL INC
Award(A)DirectStock Option
67.5K shares- - Nov 4, 2025QURE
uniQure N.V.
Exercise(M)Direct11K shares at avg. $5.37$59K - Nov 4, 2025QURE
uniQure N.V.
Sale(S)Direct10K shares at avg. $30.36$304K - Nov 4, 2025QURE
uniQure N.V.
Exercise(M)Direct10K shares at avg. $7.37$74K - Nov 4, 2025QURE
uniQure N.V.
Sale(S)Direct17.8K shares at avg. $30.33$540K - Nov 4, 2025QURE
uniQure N.V.
Exercise(M)Direct17.8K shares at avg. $14.08$251K - Nov 4, 2025QURE
uniQure N.V.
Sale(S)Direct11K shares at avg. $30.34$334K - Jun 20, 2025QURE
uniQure N.V.
Sale(S)Direct2.1K shares at avg. $14.45$31K - Jun 11, 2025QURE
uniQure N.V.
Award(A)Direct8K shares- - Mar 5, 2025DYAI
DYADIC INTERNATIONAL INC
Exercise(M)Direct7.5K shares at avg. $1.33$10K - Mar 5, 2025DYAI
DYADIC INTERNATIONAL INC
Exercise(M)Direct22.5K shares at avg. $1.33$30K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | QURE uniQure N.V. | Exercise(M) | 17,060 | $20.18 | $344,271 | Direct |
| Jun 30, 2026 | QURE uniQure N.V. | Sale(S) | 17,060 | $46.43 | $792,096 | Direct |
| Jun 30, 2026 | QURE uniQure N.V. | Sale(S) | 4,107 | $46.49 | $190,934 | Direct |
| Jun 30, 2026 | QURE uniQure N.V. | Exercise(M) | 4,107 | $37.00 | $151,959 | Direct |
| Jun 17, 2026 | QURE uniQure N.V. | Sale(S) | 5,295 | $42.57 | $225,408 | Direct |
| Jun 17, 2026 | QURE uniQure N.V. | Exercise(M) | 5,295 | $31.71 | $167,904 | Direct |
| Jun 11, 2026 | QURE uniQure N.V. | Sale(S) | 1,993 | $27.06 | $53,931 | Direct |
| Jun 10, 2026 | QURE uniQure N.V. | Award(A) | 7,550 | - | $0 | Direct |
| Jun 3, 2026 | QURE uniQure N.V. | Exercise(M) | 2,645 | $16.04 | $42,426 | Direct |
| Jun 3, 2026 | QURE uniQure N.V. | Sale(S) | 2,645 | $30.01 | $79,376 | Direct |
| Jan 9, 2026 | QURE uniQure N.V. | Exercise(M) | 6,390 | $19.39 | $123,902 | Direct |
| Jan 9, 2026 | QURE uniQure N.V. | Sale(S) | 6,390 | $27.28 | $174,319 | Direct |
| Jan 2, 2026 | DYAI DYADIC INTERNATIONAL INC | Award(A) Restricted Stock Unit | 39,894 | - | - | Direct |
| Jan 2, 2026 | DYAI DYADIC INTERNATIONAL INC | Exercise(M) | 21,552 | - | $0 | Direct |
| Jan 2, 2026 | DYAI DYADIC INTERNATIONAL INC | Award(A) Stock Option | 67,500 | - | - | Direct |
| Nov 4, 2025 | QURE uniQure N.V. | Exercise(M) | 11,000 | $5.37 | $59,070 | Direct |
| Nov 4, 2025 | QURE uniQure N.V. | Sale(S) | 10,000 | $30.36 | $303,600 | Direct |
| Nov 4, 2025 | QURE uniQure N.V. | Exercise(M) | 10,000 | $7.37 | $73,700 | Direct |
| Nov 4, 2025 | QURE uniQure N.V. | Sale(S) | 17,810 | $30.33 | $540,177 | Direct |
| Nov 4, 2025 | QURE uniQure N.V. | Exercise(M) | 17,810 | $14.08 | $250,765 | Direct |
| Nov 4, 2025 | QURE uniQure N.V. | Sale(S) | 11,000 | $30.34 | $333,740 | Direct |
| Jun 20, 2025 | QURE uniQure N.V. | Sale(S) | 2,112 | $14.45 | $30,518 | Direct |
| Jun 11, 2025 | QURE uniQure N.V. | Award(A) | 7,970 | - | - | Direct |
| Mar 5, 2025 | DYAI DYADIC INTERNATIONAL INC | Exercise(M) | 7,500 | $1.33 | $9,975 | Direct |
| Mar 5, 2025 | DYAI DYADIC INTERNATIONAL INC | Exercise(M) | 22,500 | $1.33 | $29,925 | Direct |
1-25 of 29 transactions
About Kaye Jack
Kaye Jack (SEC CIK 0001376099) files insider reports with the SEC as Director of uniQure N.V. (QURE) and Director of DYADIC INTERNATIONAL INC (DYAI).
Signal8 holds 11 ownership filings by Kaye Jack, all Form 4s, filed between Jan 7, 2025 and Jul 2, 2026. Those filings report 29 transactions, from Jan 2, 2025 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kaye Jack's filings is in AMSTERDAM.
Recent filings by Kaye Jack
- Jun 30, 2026: Option exercise of QURE shares (Form 4, code M).
- Jun 30, 2026: Open-market sales of QURE shares (2 lines, Form 4, code S).
- Jun 30, 2026: Option exercise of QURE shares (Form 4, code M).
- Jun 17, 2026: Open-market sale of QURE shares (Form 4, code S).
- Jun 17, 2026: Option exercise of QURE shares (Form 4, code M).
Other insiders filing for uniQure N.V. (QURE)
- Kapusta Matthew C, CEO, Managing Director
- Abi-Saab Walid, Chief Medical Officer
- Balachandran Madhavan, Director
- Potts Jeannette, Chief Legal Officer
- Meek David D., Director
- Gut Robert, Director